BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11347559)

  • 21. Efficacy and Safety of Oral GnRh Antagonists in Patients With Uterine Fibroids: A Systematic Review.
    Niaz R; Saeed M; Khan H; Ali MA; Irshad A; Faiz M; Irshad A; Fatima F; Tunio SA; Aiman W
    J Obstet Gynaecol Can; 2022 Dec; 44(12):1279-1288. PubMed ID: 36368594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of uterine fibroids with agonist analogs of gonadotropin-releasing hormone.
    Kessel B; Liu J; Mortola J; Berga S; Yen SS
    Fertil Steril; 1988 Mar; 49(3):538-41. PubMed ID: 3277869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix.
    Gonzalez-Barcena D; Alvarez RB; Ochoa EP; Cornejo IC; Comaru-Schally AM; Schally AV; Engel J; Reissmann T; Riethmüller-Winzen H
    Hum Reprod; 1997 Sep; 12(9):2028-35. PubMed ID: 9363724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective estrogen receptor modulator and selective progesterone receptor modulator: therapeutic efficacy in the treatment of uterine leiomyoma.
    Ohara N
    Clin Exp Obstet Gynecol; 2005; 32(1):9-11. PubMed ID: 15864926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of gonadotropin-releasing hormone agonists on leiomyomas.
    Mesia AF; Popiolek D
    Arch Pathol Lab Med; 1999 Apr; 123(4):282-3. PubMed ID: 10320136
    [No Abstract]   [Full Text] [Related]  

  • 26. Prediction of the effects of gonadotropin-releasing hormone agonist therapy in uterine leiomyoma by T1 contrast-enhanced magnetic resonance imaging sequences.
    Kadowaki M; Murakami T; Morita J; Terada Y; Yaegashi N; Okamura K
    Fertil Steril; 2002 May; 77(5):1081-2. PubMed ID: 12009376
    [No Abstract]   [Full Text] [Related]  

  • 27. Real world data of 1473 patients treated with ulipristal acetate for uterine fibroids: Premya study results.
    Fernandez H; Schmidt T; Powell M; Costa AP; Arriagada P; Thaler C
    Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():91-96. PubMed ID: 27898340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical practice. Uterine fibroids.
    Stewart EA
    N Engl J Med; 2015 Apr; 372(17):1646-55. PubMed ID: 25901428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ulipristal acetate for use in moderate to severe symptoms of uterine fibroids.
    Talaulikar VS; Manyonda I
    Womens Health (Lond); 2014 Nov; 10(6):565-70. PubMed ID: 25482483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of GnRH agonists in the treatment of uterine fibroids.
    Healy DL; Vollenhoven BJ
    Br J Obstet Gynaecol; 1992 Feb; 99 Suppl 7():23-6. PubMed ID: 1554685
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibroids (uterine myomatosis, leiomyomas).
    Lethaby A; Vollenhoven B
    Clin Evid; 2004 Dec; (12):2563-85. PubMed ID: 15865807
    [No Abstract]   [Full Text] [Related]  

  • 32. Severe Multiple Sclerosis Manifesting upon GnRH Agonist Therapy for Uterine Fibroids.
    Sakurai K; Shinohara K; Imai T; Yamano Y; Hasegawa Y
    Intern Med; 2020 Dec; 59(23):3093-3096. PubMed ID: 32759585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical management of fibroids.
    Baird DT; West CP
    Br Med J (Clin Res Ed); 1988 Jun; 296(6638):1684-5. PubMed ID: 3135875
    [No Abstract]   [Full Text] [Related]  

  • 34. Depot GnRH analog treatment of uterine fibroids.
    Loverro G; Nicolardi V; Selvaggi L
    Int J Gynaecol Obstet; 1993 Nov; 43(2):199-201. PubMed ID: 7905441
    [No Abstract]   [Full Text] [Related]  

  • 35. GnRH-antagonists in reproductive medicine.
    Griesinger G; Felberbaum R; Diedrich K
    Arch Gynecol Obstet; 2005 Dec; 273(2):71-8. PubMed ID: 15991015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral gonadotrophin-releasing hormone (GnRH) antagonists: the continuing search for the ideal nonsurgical therapy of uterine fibroids with a cautionary tale.
    Sim-Ifere O; Aref-Adib M; Odejinmi F
    Curr Opin Obstet Gynecol; 2023 Oct; 35(5):460-465. PubMed ID: 37560806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [GnRH analogues in the management of uterine leiomyoma].
    Matsuo H; Maruo T
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():75-9. PubMed ID: 16689288
    [No Abstract]   [Full Text] [Related]  

  • 38. [Medical treatment of uterine fibroids with the LHRH antagonist: Cetrorelix].
    Felberbaum RE; Ludwig M; Diedrich K
    Contracept Fertil Sex; 1999 Oct; 27(10):701-9. PubMed ID: 10605180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Other medical management of uterine fibroids.
    Eldar-Geva T; Healy DL
    Baillieres Clin Obstet Gynaecol; 1998 Jun; 12(2):269-88. PubMed ID: 10023422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Medical Management for Uterine Leiomyomas.
    Kashani BN; Centini G; Morelli SS; Weiss G; Petraglia F
    Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():85-103. PubMed ID: 26796059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.